These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 31127967

  • 1. Late-onset visceral varicella-zoster virus infection presented as acute liver failure after allogeneic hematopoietic stem cell transplantation.
    Kikuchi T, Arai M, Koda Y, Kato J, Shimizu T, Katano H, Fujii-Nishimura Y, Sakamoto M, Ebinuma H, Nakamoto N, Kanai T, Okamoto S, Mori T.
    Transpl Infect Dis; 2019 Aug; 21(4):e13121. PubMed ID: 31127967
    [Abstract] [Full Text] [Related]

  • 2. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation.
    Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y.
    Int J Infect Dis; 2014 Feb; 19():26-32. PubMed ID: 24211377
    [Abstract] [Full Text] [Related]

  • 3. Visceral varicella zoster virus infection after allogeneic stem cell transplantation.
    Doki N, Miyawaki S, Tanaka M, Kudo D, Wake A, Oshima K, Fujita H, Uehara T, Hyo R, Mori T, Takahashi S, Okamoto S, Sakamaki H, Kanto Study Group for Cell Therapy.
    Transpl Infect Dis; 2013 Jun; 15(3):314-8. PubMed ID: 23551634
    [Abstract] [Full Text] [Related]

  • 4. Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation.
    Umezawa Y, Kakihana K, Oshikawa G, Kobayashi T, Doki N, Sakamaki H, Ohashi K.
    Transpl Infect Dis; 2014 Apr; 16(2):195-202. PubMed ID: 24438510
    [Abstract] [Full Text] [Related]

  • 5. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M.
    Am J Hematol; 2008 Jun; 83(6):472-6. PubMed ID: 18266207
    [Abstract] [Full Text] [Related]

  • 6. Visceral varicella zoster virus (VZV) after allogeneic hematopoietic stem cell transplant (HSCT) in pediatric patients with chronic graft-versus-host disease (cGVHD).
    Peritz DC, Duncan C, Kurek K, Perez-Atayde AR, Lehmann LE.
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):931-4. PubMed ID: 19131784
    [Abstract] [Full Text] [Related]

  • 7. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Kanda Y, Mineishi S, Saito T, Saito A, Yamada S, Ohnishi M, Chizuka A, Niiya H, Suenaga K, Nakai K, Takeuchi T, Makimoto A, Tanosaki R, Kami M, Tanaka Y, Fujita S, Watanabe T, Kobayashi Y, Tobinai K, Takaue Y.
    Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
    [Abstract] [Full Text] [Related]

  • 8. Low-dose acyclovir for prophylaxis of varicella-zoster virus reactivation after hematopoietic stem cell transplantation in children.
    Tatebe Y, Ushio S, Esumi S, Sada H, Ochi M, Tamefusa K, Ishida H, Fujiwara K, Kanamitsu K, Washio K, Katsube R, Murakawa K, Zamami Y.
    Pediatr Blood Cancer; 2022 Dec; 69(12):e29979. PubMed ID: 36151963
    [Abstract] [Full Text] [Related]

  • 9. The Successful Treatment of a Cord Blood Transplant Recipient with Varicella Zoster Virus Meningitis, Radiculitis and Myelitis with Foscarnet.
    Shimizu R, Ohwada C, Nagao Y, Togasaki E, Kawajiri C, Muto T, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Iseki T, Nakaseko C.
    Intern Med; 2017 Dec; 56(3):353-356. PubMed ID: 28154282
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of acyclovir prophylaxis against varicella zoster virus disease after allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis.
    Wada-Shimosato Y, Tanoshima R, Hiratoko K, Takeuchi M, Tsujimoto SI, Shiba N, Ito S, Yamanaka T, Ito S.
    Transpl Infect Dis; 2019 Jun; 21(3):e13061. PubMed ID: 30756465
    [Abstract] [Full Text] [Related]

  • 11. Persistence and antiviral resistance of varicella zoster virus in hematological patients.
    van der Beek MT, Vermont CL, Bredius RG, Marijt EW, van der Blij-de Brouwer CS, Kroes AC, Claas EC, Vossen AC.
    Clin Infect Dis; 2013 Feb; 56(3):335-43. PubMed ID: 23074321
    [Abstract] [Full Text] [Related]

  • 12. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
    Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK, Lee V, Yuen PM.
    Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
    [Abstract] [Full Text] [Related]

  • 13. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Aoki T, Koh K, Kawano Y, Mori M, Arakawa Y, Kato M, Hanada R.
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
    [Abstract] [Full Text] [Related]

  • 14. Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains high.
    Blennow O, Fjaertoft G, Winiarski J, Ljungman P, Mattsson J, Remberger M.
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1646-9. PubMed ID: 24914821
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Ma CK, Blyth E, Clancy L, Simms R, Burgess J, Brown R, Deo S, Micklethwaite KP, Gottlieb DJ.
    Cytotherapy; 2015 Oct; 17(10):1406-20. PubMed ID: 26349000
    [Abstract] [Full Text] [Related]

  • 17. One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group.
    Oshima K, Takahashi T, Mori T, Matsuyama T, Usuki K, Asano-Mori Y, Nakahara F, Okamoto S, Kurokawa M, Kanda Y.
    Transpl Infect Dis; 2010 Oct; 12(5):421-7. PubMed ID: 20626711
    [Abstract] [Full Text] [Related]

  • 18. Long-Term Incidence of Varicella Zoster Virus Disease in Adults Receiving Single-Unit Cord Blood Transplantation.
    Fukushi K, Konuma T, Monna-Oiwa M, Isobe M, Kato S, Kuroda S, Takahashi S, Nannya Y.
    Transplant Cell Ther; 2022 Jun; 28(6):339.e1-339.e7. PubMed ID: 35364334
    [Abstract] [Full Text] [Related]

  • 19. Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantation.
    Suzuki J, Ashizawa M, Okuda S, Wada H, Sakamoto K, Terasako K, Sato M, Kimura SI, Kikuchi M, Nakasone H, Kako S, Yamazaki R, Oshima K, Nishida J, Kanda Y.
    Transpl Infect Dis; 2012 Aug; 14(4):E7-12. PubMed ID: 22340704
    [Abstract] [Full Text] [Related]

  • 20. Varicella Zoster Virus Infection in Children with Autologous Hematopoietic Cell Transplantation: A Retrospective, Single-Center Study in Korea.
    Kang JM, Kim JM, Lee JW, Yoo KH, Sung KW, Koo HH, Kim YJ.
    Biol Blood Marrow Transplant; 2020 May; 26(5):965-971. PubMed ID: 31962166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.